Reduction of Bacteria in MRSA Positive Ulcers

NCT00771368 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine if gaseous nitric oxide is effective in the treatement of bacteria in MRSA positive ulcers

Conditions

  • Leg Ulcer
  • Pressure Ulcer

Interventions

DRUG

Nitric Oxide

1 % Gaseous Nitric Oxide, delivered for 30 minutes daily for 3 consecutive days

Sponsors & Collaborators

  • Nitric BioTherapeutics, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-05-31
Completion
2009-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00771368 on ClinicalTrials.gov